Alvarez NS, Quiñones AS, Plascencia ÁNI, Sauri SS, Núñez OL

Language: Spanish
References: 20
Page: 142-149
PDF size: 63.14 Kb.

ABSTRACT

Multiple Sclerosis is the first cause of disability in young people due to neurological illnesses, with the highest incidence between 20 and 40 years of age, reason why it bears an important economic, social and family impact, deteriorating the quality of life. Their symptoms vary according to the evolutionary moment of the illness, its clinical form and the topography of the lesions. It is thought that permanent symptoms, due to the incomplete recovery after a relapse or due to progression of the illness, usually impair the quality of the individual’s life. Some of them are fatigue, spasticity, intestinal and/or bladder dysfunction, pain, neuralgia, vertigo, and sexual dysfunction among others; in this study we investigate the impact in the quality of life in patients with Multiple Sclerosis and sexual dysfunction, which is classified as primary, secondary and tertiary. Methods: We included in this study 35 patients with Multiple Sclerosis who were submitted to the Expanded Disability Scale Status (EDSS), MSISQ-19 for sexual dysfunction in patients with Multiple Sclerosis and the MusiQoL to evaluate the quality of life. Results: We found an average age of 40.3 years (range 23 to 55 years) with an EDSS score of 2.8 and a frequency of Primary Sexual Dysfunction of 86.6%, 41.93%, male and 50.06% female; 86.6% had Secondary Sexual Dysfunction, 38.7% male and 61.29% female. The Tertiary dysfunction was found in 74.3%, 38.46% male and 61.53% female. Conclusions: This study showed evidences that people with EM without sexual dysfunction have a better quality of life than people with it, however the differences are not significant.

REFERENCES

1. Moreira MA, Tilbery CP, et al. Aspectos históricos de la esclerosis múltiple. Rev. Neurol 2002; 34(4): 378-83.

2. Romero R. Rivera P. Sobre esclerosis múltiple, a propósito de un caso. CIMEL 2004; 9(1): 41-45

3. Noseworthy JH, MD Multiple Sclerosis. New England Journal of Medicine 2000; 343(13): 938-52.

4. Uria DF. Epidemiología de la Esclerosis Múltiple. Rev Neurol 2002; 35(10): 979-84.

5. de la Maza M, García J. Revisión de la epidemiología de la Esclerosis Múltiple en México. Rev Neurol 2000; 31(5): 494-95.

6. AMMEEM. El manejo integral de los pacientes con Esclerosis Múltiple. Editorial Prado; 2003.

7. Rivera-Navarro J et al, Hacia la búsqueda de dimensiones máí especificas en la medición de la calidad de vida en la Esclerosis Múltiple, Rev Neurol 2001; 32(8): 705-13.

8. Murria TJ. Diagnosis and treatment of Multiple Sclerosis. BMJ 2006; 332: 525-27

9. Mc Donald WI. Recomended diagnostic criteria for Multiple Sclerosis: Guidelines from de international panel on the diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121-27.

10. Diagnostic criteria for Multiple Sclerosis: 2005, Revisions to the “Mc Donald Criteria” Ann Neurol 2005; 58: 840-46.

11. Fowler CJ. Neurologic Bladder, Bowel and Sexual Dysfunction. Seminars in Clinical Neurology. 2001: 38-50.

12. Tullman M. Sympotamic therapy in multiple sclerosis. Continuum 2004; 10(6): 142-63.

13. Velásquez-Quintana M, Macias-Islas MA. Esclerosis Multiple en México: un estudio multicéntrico. Rev Neurol 2003; 36(11): 1019-22.

14. Ayuso L, et al. Tratamiento sintomático de la esclerosis multiple. Rev Neurol 2002; 35(12): 1141-53

15. Rona Rubin MA, et al. Communication about sexal problems in male patients with multiple sclerosis. Nursing Standard 2004; 28(19): 33-37

16. Sorgen SA, PhD., et al. The Multiple Sclerosis Intimacy and Sexuality Questionnaire-19(MSISQ-19) Sexuality and Disability 2000; 18(1): 3-19.

17. Crayton H, MD et al. Neurology 2004; 63(11): S12-S18

18. Harrison. Principles of internal medicine. 16 edition 2006, 306-11.

19. Mattson D, et al. Multiple Sclerosis. Sexual Dysfunction and its response to medications. Arch Neurol 2001; 52: 862.

20. L. Ayuso-Peralta Tratamiento sintomático de la esclerosis múltiple. Rev Neurol 2002; 35(12): 1441-53.